Literature DB >> 26659898

Validation of the EORTC QLQ-INFO 25 questionnaire in Lebanese cancer patients: Is ignorance a Bliss?

Samer Tabchi1, Elie El Rassy2, Aline Khazaka2, Fadi El Karak2, Hampig Raphael Kourie3, Ralph Chebib2, Tarek Assi2, Maya Ghor2, Lara Naamani2, Sami Richa4, Marwan Ghosn2, Joseph Kattan2.   

Abstract

INTRODUCTION: Despite worldwide trends toward optimizing full disclosure of information (DOI), the prevailing belief that cancer diagnosis should be concealed from patients, for their own good, has endured for a substantial period of time in Middle Eastern communities.
OBJECTIVES: This study would assess the reliability of the Arabic translated version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-INFO 25). The study was also designed to quantify DOI to Lebanese cancer patients and determine patient satisfaction with this DOI. Moreover, we compared the differences in the level of information among groups based on clinical and biographical variables.
METHODS: A sample of patients, being treated for a variety of malignancies, was prospectively evaluated. A physician interviewed patients using the Arabic version of the EORTC QLQ-INFO 25, on the day of hospitalization for chemotherapy, before treatment was administered.
RESULTS: In total 201 patients were interviewed. The translated version of the EORTC QLQ-INFO 25 showed high reliability when assessed using Cronbach's alpha coefficients for internal consistency with values scoring higher than 0.7 for all scales and the full questionnaire. There was a considerable lack of information provided to the participants with 38.8 % being unaware of their diagnosis and more than half being uninformed about the extent of their disease. Paradoxically, 86.5 % of patients expressed their satisfaction about the amount of information they received and 89.5 % believe the information provided was helpful. Further analysis showed no significant association between gender, marital status, cancer site and stage and the amount of information received. However, age and level of education were associated with DOI such as younger and more educated patients received more information. Older patients were also found to be the most satisfied with the information they received, despite having less access to information.
CONCLUSIONS: Although a high proportion of patients were not properly informed about their diagnosis, the overwhelming majority were satisfied with the amount of information they received and believed it was useful, reflecting the complexity of Middle Eastern cultural influences on cancer patients' perspectives.

Entities:  

Keywords:  Cancer diagnosis; Concealment of information; Disclosure of information; EORTC QLQ-INFO 25 Arabic; Patient satisfaction

Mesh:

Year:  2015        PMID: 26659898     DOI: 10.1007/s11136-015-1201-6

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  26 in total

Review 1.  Disclosure and prevention of medical errors. Committee on Bioethical Issues of the Medical Society of the State of New York.

Authors:  F Rosner; J T Berger; P Kark; J Potash; A J Bennett
Journal:  Arch Intern Med       Date:  2000-07-24

2.  What to tell cancer patients. A study of medical attitudes.

Authors:  D OKEN
Journal:  JAMA       Date:  1961-04-01       Impact factor: 56.272

3.  Should patients with Alzheimer's disease be told their diagnosis?

Authors:  M A Drickamer; M S Lachs
Journal:  N Engl J Med       Date:  1992-04-02       Impact factor: 91.245

4.  Truth telling to the patient.

Authors:  A Surbone
Journal:  JAMA       Date:  1992-10-07       Impact factor: 56.272

5.  An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients.

Authors:  Juan Ignacio Arraras; Eva Greimel; Orhan Sezer; Wei-Chu Chie; Mia Bergenmar; Anna Costantini; Teresa Young; Karin Kuljanic Vlasic; Galina Velikova
Journal:  Eur J Cancer       Date:  2010-07-30       Impact factor: 9.162

6.  Prognostic disclosure to patients with cancer near the end of life.

Authors:  E B Lamont; N A Christakis
Journal:  Ann Intern Med       Date:  2001-06-19       Impact factor: 25.391

7.  The cancer patient: communication and morale.

Authors:  T B Brewin
Journal:  Br Med J       Date:  1977 Dec 24-31

8.  Changes in physicians' attitudes toward telling the cancer patient.

Authors:  D H Novack; R Plumer; R L Smith; H Ochitill; G R Morrow; J M Bennett
Journal:  JAMA       Date:  1979-03-02       Impact factor: 56.272

9.  Psychological state, quality of life, and coping style in patients with digestive cancer.

Authors:  Toshiko Matsushita; Eisuke Matsushima; Michio Maruyama
Journal:  Gen Hosp Psychiatry       Date:  2005 Mar-Apr       Impact factor: 3.238

10.  Anxiety and depression in patients with gastrointestinal cancer: does knowledge of cancer diagnosis matter?

Authors:  Azadeh Tavoli; Mohammad Ali Mohagheghi; Ali Montazeri; Rasool Roshan; Zahra Tavoli; Sepideh Omidvari
Journal:  BMC Gastroenterol       Date:  2007-07-14       Impact factor: 3.067

View more
  3 in total

1.  Factors associated with the time to first palliative care consultation in Lebanese cancer patients.

Authors:  Ziad Bakouny; Tarek Assi; Elie El Rassy; Karen Daccache; Clarisse Kattan; Aline Tohme; Marie Claire Mouhawej; Joseph Kattan
Journal:  Support Care Cancer       Date:  2018-11-07       Impact factor: 3.603

2.  The role of palliative care in the last month of life in elderly cancer patients.

Authors:  Tarek Assi; Elie El Rassy; Tony Ibrahim; Tania Moussa; Aline Tohme; Fadi El Karak; Fadi Farhat; Salma Faddoul; Marwan Ghosn; Joseph Kattan
Journal:  Support Care Cancer       Date:  2016-10-13       Impact factor: 3.603

Review 3.  Comprehensive review into the challenges of gastrointestinal tumors in the Gulf and Levant countries.

Authors:  Fadi Farhat; Abdulaziz Al Farsi; Ahmed Mohieldin; Bassim Al Bahrani; Eman Sbaity; Hassan Jaffar; Joseph Kattan; Kakil Rasul; Khairallah Saad; Tarek Assi; Waleed El Morsi; Rafid A Abood
Journal:  World J Clin Cases       Date:  2020-02-06       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.